Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons.
about
Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's diseaseAntagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid β neurotoxicity in vitroNeuroinflammation in Alzheimer's diseaseProstaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease.Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis.Reduction of amyloid angiopathy and Abeta plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways.Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticusAnti-inflammatory effects of kinins via microglia in the central nervous system.Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2.Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2.Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementiaRoles of the prostaglandin E2 receptors EP subtypes in Alzheimer's disease.Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.Melatonin Attenuates Manganese and Lipopolysaccharide-Induced Inflammatory Activation of BV2 Microglia.Hippocampal neuronal cyclooxygenase-2 downstream signaling imbalance in a rat model of chronic aluminium gluconate administration.Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease.
P2860
Q24647957-80EF072B-1F14-4F30-8F5E-4E04A5A0E6BDQ26861848-56C6ED43-80D8-4474-AFDA-1A4AA908CBF9Q28259238-92C1A282-7BE4-44E6-BA18-E1C44BC88102Q30634663-6F6BBDCC-8FC7-4028-8312-E1459FB2C385Q34551101-EB1B67AB-6F2D-48C8-875B-12052A2623F3Q34780834-802797F6-8F61-4C4F-AE5B-8E448E30318EQ35222000-0D98C3FA-251A-42B3-BA05-A73ED1B4D12AQ35534894-6922A174-30E0-4F1E-B15E-6BC13D855E5DQ36404480-B26AD09C-6DE3-455E-A9DF-FCCB052416EDQ36833728-2EFDE347-15F4-4D22-8ED5-41C3B6C97CCFQ37101754-89877195-64FA-4D47-9623-87B725348B3EQ37197399-72522AD8-428F-4290-8540-4D746930479EQ37211768-9C74AC4A-FA4E-4A39-9C3A-D0B985B0C277Q37681315-90722054-75F3-4302-9378-FBB913DD09D9Q37703299-A2B7824D-6D14-4305-B486-162C7B75242BQ38728319-BB7A573E-B5C3-42A3-BA42-523112C67D26Q43157877-876542E0-AA31-41E1-82AC-C245B9720E4EQ43224814-C3731189-5C56-4746-BF01-4E95C01D77A5
P2860
Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Microglial EP2 as a new target ...... eta-induced damage to neurons.
@ast
Microglial EP2 as a new target ...... eta-induced damage to neurons.
@en
type
label
Microglial EP2 as a new target ...... eta-induced damage to neurons.
@ast
Microglial EP2 as a new target ...... eta-induced damage to neurons.
@en
prefLabel
Microglial EP2 as a new target ...... eta-induced damage to neurons.
@ast
Microglial EP2 as a new target ...... eta-induced damage to neurons.
@en
P2093
P2860
P1433
P1476
Microglial EP2 as a new target ...... eta-induced damage to neurons.
@en
P2093
Feng-Shiun Shie
Kathleen S Montine
Richard M Breyer
Thomas J Montine
P2860
P304
P356
10.1111/J.1750-3639.2005.TB00509.X
P577
2005-04-01T00:00:00Z